Compare VOR & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | TRNS |
|---|---|---|
| Founded | 2015 | 1964 |
| Country | United States | United States |
| Employees | N/A | 1413 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.3M | 858.2M |
| IPO Year | 2021 | 1995 |
| Metric | VOR | TRNS |
|---|---|---|
| Price | $15.60 | $91.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $45.33 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 866.9K | 181.6K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | ★ N/A | $161.19 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $1.11 | $50.23 |
| 52 Week High | $49.95 | $94.76 |
| Indicator | VOR | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 58.52 |
| Support Level | $11.95 | $68.27 |
| Resistance Level | $16.87 | $94.48 |
| Average True Range (ATR) | 0.96 | 3.76 |
| MACD | 0.19 | -0.41 |
| Stochastic Oscillator | 81.35 | 65.00 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.